Trials / Completed
CompletedNCT06717529
Functional and Clinical Outcomes of Hyaluronic Acid and Steroid Injections in Bilateral Knee Osteoarthritis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Edin Mešanović · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare functional and clinical outcomes of intraarticular injections of hyaluronic acid and steroids in patients with bilateral knee osteoarthritis. We will compare clinical and functional outcomes for each knee separately after week 6, month 3, month 6, and one year after the intervention.
Detailed description
We will include patients with bilateral knee osteoarthritis (Kellgren Lawrence grades 2 and 3). On initial examination, we will measure active and passive range of flexion and extension, presence of swelling, joint effusion, VAS score for each knee separately, and WOMAC score for every knee separately. We will randomly apply hyaluronic acid injection in one knee and steroid injection in the other knee. We will repeat the same examination after week 6, month 3, month 6, and one year after the procedure. The main aim is to check whether there is a significant clinical or functional difference between two groups.
Conditions
- Osteoarthritis (OA) of the Knee
- Osteoarthritis
- Osteoarthritis in the Knee
- Osteoarthritis of Knee
- Osteoarthritis of the Knees
- Osteoarthritis of Knee Joint
- Osteoarthritis Knee
- Osteoarthritis of the Knee
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sodium hyaluronate (hyaluronic acid) | The patient will receive one 3mL Sodium Hyaluronate injection containing 75 mg of active substance in one knee joint. |
| DRUG | Methylprednisolone Acetate Injection | The patient will receive 2mL of methylprednisolone acetate solution containing 80 mg of the medicine in other knee joint. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-11-15
- Completion
- 2024-09-30
- First posted
- 2024-12-05
- Last updated
- 2024-12-05
Locations
1 site across 1 country: Bosnia and Herzegovina
Source: ClinicalTrials.gov record NCT06717529. Inclusion in this directory is not an endorsement.